Medication Assisted Treatment For Opioid …...treatment of opioid addiction. SAMHSA’s Center for Substance Abuse Treatment (CSAT) manages the day-to-day regulatory oversight activities

Medication-Assisted Treatment for Opioid Addiction

2010 State Profiles

Medication-Assisted Treatment for Opioid Addiction

2010 State Profiles

U.S. Department of Health and Human Services

Substance Abuse and Mental Health Services Administration

Center for Substance Abuse Treatment

Medication-Assisted Treatment for Opioid Addiction: 2010 State Profiles

Acknowledgements This report was prepared by Leslie Ann Ba and Willie Tompkins, Jr., Ph.D., for the Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services (HHS).

Contact Information

For further information contact the Center for Substance Abuse Treatment, Division of Pharmacologic Therapies at (240) 276-2700 ([email protected]); or Division of State and Community Assistance/Performance Measurement Branch at (240) 276-2858.

Disclaimer

The views, opinions, and content of this publication are those of the author and do not necessarily reflect the views, opinions, or policies of SAMHSA or HHS.

Public Domain Notice

All material appearing in this report is in the public domain and may be reproduced or copied without permission from SAMHSA. Citation of the source is appreciated. However, this publication may not be reproduced or distributed for a fee without the specific, written authorization of the Office of Communications, SAMHSA, HHS.

Electronic Access and Copies of Publication

This publication may be downloaded or ordered at store.samhsa.gov. Or call 1-877-SAMHSA-7 (1-877-726-4727) (English and Español).

Recommended Citation

Substance Abuse and Mental Health Services Administration, Medication-Assisted Treatment for Opioid Addiction: 2010 State Profiles, Substance Abuse and Mental Health Services Administration, 2011.

Originating Office

Division of Pharmacologic Therapies and Division of State and Community Assistance, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, 1 Choke Cherry Road, Rockville, MD 20857.

HHS Publication No. (SMA)-11-4643 Printed 2011

Table of Contents Acknowledgements ........................................... 3

Table of Contents ............................................... 4

About Medication-Assisted Treatment (MAT) ..... 5

United States ..................................................... 7

Highlights ......................................................... 10

Alabama ............................................................11

Alaska .............................................................. 14

Arizona ............................................................ 17

Arkansas........................................................... 20

California ......................................................... 23

Colorado ........................................................... 26

Connecticut ...................................................... 29

Delaware ......................................................... 32

District of Columbia .......................................... 35

Georgia ............................................................ 41

Hawaii .............................................................. 44

Idaho ................................................................ 47

Illinois ............................................................... 49

Indiana ............................................................. 52

Iowa ................................................................. 55

Kansas ............................................................. 58

Kentucky .......................................................... 61

Louisiana ......................................................... 64

Maine ............................................................... 67

Maryland .......................................................... 70

Massachusetts ................................................. 73

Michigan .......................................................... 76

Minnesota ........................................................ 79

Mississippi ....................................................... 82

Missouri ........................................................... 85

Montana ........................................................... 88

Nebraska ......................................................... 90

Nevada ............................................................ 93

New Hampshire ............................................... 96

New Jersey ...................................................... 99

New Mexico ................................................... 102

New York ....................................................... 105

North Carolina ............................................... 108

North Dakota ..................................................111

Ohio ................................................................112

Oklahoma .......................................................115

Oregon ............................................................118

Pennsylvania ................................................. 121

Rhode Island ................................................. 124

South Carolina ............................................... 127

South Dakota ................................................. 130

Tennessee ..................................................... 131

Texas ............................................................. 134

Utah ............................................................... 137

Vermont ......................................................... 140

Virginia ........................................................... 143

Washington .................................................... 146

West Virginia ................................................. 149

Wisconsin ...................................................... 152

Wyoming ........................................................ 155

Guam ............................................................. 156

Puerto Rico .................................................... 157

U.S. Virgin Islands ......................................... 160

Appendix A ..................................................... 162

About Medication-Assisted Treatment (MAT)Medication-assisted treatment involves the use of medications, in combination with counseling and behavioral therapies, for the treatment of substance use disorders. Research shows that when treating certain substance use disorders, a combination of medication and behavioral therapies is regarded as most successful when treating the disorders. Medication-assisted treatment is clinically driven with a focus on individualized patient care.

The Substance Abuse and Mental Health Services Administration (SAMHSA) of the U.S. Department of Health and Human Services certifies Opioid Treatment Programs (OTPs) that provide methadone and buprenorphine to treat individuals addicted to opioids such as heroin, oxycodone, or hydrocodone. Currently, methadone and buprenorphine are the only scheduled opioid medications approved for the treatment of opioid addiction. SAMHSA’s Center for Substance Abuse Treatment (CSAT) manages the day-to-day regulatory oversight activities necessary to implement SAMHSA regulations, 42 CFR Part 8, on the use of opioid agonist medications (methadone and buprenorphine) approved by the Food and Drug Administration (FDA) for addiction treatment. These activities include supporting the certification of over 1,200 OTPs that collectively treat over 270,000 patients daily.

CSAT manages the operational requirements of the Drug Addiction Treatment Act of 2000 (DATA 2000), which expands the clinical context of medication-assisted opioid addiction treatment by allowing qualified physicians to dispense or prescribe specifically approved Schedule III, IV, and V narcotic medications for the treatment of opioid addiction in treatment settings other than the traditional opioid treatment program. Currently, the only medications that meet the statutory provisions of DATA 2000 are buprenorphine and buprenorphine in combination with naloxone. Additionally, CSAT supports the training of medical and substance abuse professionals on a variety of treatment issues including the use of methadone and buprenorphine. For additional information visit http://www.dpt.samhsa.gov/.

Methadone

Methadone is a synthetic opioid that blocks the effects of heroin and other prescription drugs containing opioids. Used successfully for more than 40 years in treating opioid addiction, methadone has been shown to eliminate withdrawal symptoms and relieve drug cravings from heroin and prescription opioid medications. Methadone is a medication that prevents opioid withdrawal symptoms for up to 36 hours and must be taken daily. Taken as directed, methadone:

• blocks the euphoric and sedating effects of opioids;

• relieves the craving for opioids that is a major factor in relapse;

• relieves symptoms associated with withdrawal from opioids;

• does not cause euphoria or intoxication itself (with stable dosing), thus allowing a person to work and participate normally in society; and

• is excreted slowly so it can be taken only once a day.

The use of methadone for medication-assisted treatment was developed in the 1960s, and is a form of pharmacotherapy for the treatment of addiction or dependence to opioids, which includes a pharmaco-logic intervention as part of a comprehensive substance abuse treatment plan, with an ultimate goal of patient recovery with full social function.

Methadone has been demonstrated to reduce mortality, decrease transmission of HIV and other blood-borne illnesses, and improve maternal and fetal outcomes during pregnancy. In light of these well-established benefits, it is important to recognize that there may be side effects of methadone, some of which may be severe and in some cases fatal, including cardiac arrhythmia and the risk of respiratory depression and overdose.

Buprenorphine

Buprenorphine is a medication used for detoxification and maintenance therapy in the treatment of opioid addiction. It works by blocking withdrawal and craving without producing euphoric effects. It is the only opioid addiction treatment medication that can be prescribed by a physician in an office setting. The brand names Subutex® and Suboxone® are prescription medicines that both contain buprenor-phine and treat opioid addiction by preventing symptoms of withdrawal from heroin and other opioids. Subutex® contains only buprenorphine hydrochloride, while Suboxone® contains the additional ingredi-ent naloxone to guard against misuse.

While the safety profile of buprenorphine--a partial opioid agonist--is generally better than full opioid agonists, the risk of central nervous system (CNS) depression still exists and caution must be used, particularly in cases where other CNS depressants are present.

The Drug Addiction Treatment Act of 2000 (DATA 2000)

This act enables qualifying physicians to receive a waiver from the special registration requirements in the Controlled Substances Act for the provision of medication-assisted opioid therapy. This waiver allows qualifying physicians to practice medication-assisted opioid addiction therapy with Schedule III, IV, or V narcotic medications specifically approved by the FDA. On October 8, 2002, Subutex® (buprenorphine hydrochloride) and Suboxone® tablets (buprenorphine hydrochloride and naloxone hydrochloride) received FDA approval for the treatment of opioid addiction. Subsequently in 2009 and 2010, the FDA approved two generic versions of Subutex®.

To receive a waiver, a physician must notify SAMHSA of his or her intent to begin dispensing or pre-scribing this treatment. The Notification of Intent must contain information on the physician’s qualifying credentials and additional certifications including that the physician has the capacity to refer such addiction therapy patients for appropriate counseling and other non-pharmacologic therapies, and that the physician will not have more than 100 patients on such addiction therapy at any one time. When the waiver is received, the physician may then begin using buprenorphine for the treatment of opioid addic-tion. For additional information visit http://buprenorphine.samhsa.gov/.

State Opioid Addiction Treatment System Maps

Within this report, two maps are presented for each state: Certified OTPs and DATA Certified Physicians. The maps are intended to provide an overview of locations and were produced using street addresses. Location points on both types of individual state maps may overlap due to multiple sites in close proximity to one another.

A searchable directory of more than 11,000 drug and alcohol treatment programs that shows the location of facilities around the country that treat alcoholism and alcohol and drug abuse problems is available at http://findtreatment.samhsa.gov. A physician locator that similarly identifies physicians who are authorized to prescribe buprenorphine is available at http://buprenorphine.samhsa.gov/bwns_locator.

United States These two maps present an overview of medication-assisted therapy in the States and territories of the United States. They focus particular attention on SAMHSA certified OTPs that provide medication-assisted therapy to treat individuals addicted to opioids such as heroin, oxycodone, or hydrocodone. The first map shows the States with OTPs, and the second shows the number of patients. New York, California, and Texas have the largest number of OTPs at 152, 146 and 78 respectively.

Number of Opioid Treatment Programs (March 2010)

Total Number of OTPs: 1,216

Source: SAMHSA, CSAT. OTP Database. March 2010.

*No data were reported by Idaho and Montana for March 31, 2008.

Number of Patients (March 31, 2008) in the U.S.

Total Number of Patients in OTPs: 272,351

Source: SAMHSA, CBHSQ. National Survey of Substance Abuse Treatment Services (N-SSATS). March 31, 2008.

The map below presents the number of physicians who have a waiver to prescribe or dispense buprenorphine and the number of patients in OTPs by State. New York, California, and Pennsylvania have the largest number of physicians who dispense buprenorphine at approximately 2,096, 2,087, and 1,165 respectively. However, New York, California, and Minnesota have the three largest numbers of patients receiving buprenorphine via OTPs.

Number of DATA Waived Physicians by State (March 2010)

Total Number of Physicians: 18,842


Total Number of Patients Receiving Buprenorphine via OTPs: 4,280


Highlights SAMHSA’s Center for Behavioral Health Statistics and Quality (CBHSQ) conducts the National Survey of Substance Abuse Treatment Services (N-SSATS), an annual census survey of all known facilities in the United States, both public and private, that provide substance abuse treatment. The overall response rate for the 2008 survey was 94.1 percent, and N-SSATS provides point prevalence data. Major highlights from the 2008 N-SSATS, conducted on March 31, 2008, are listed below.

• Of the 13,688 facilities responding to N-SSATS, OTPs certified by SAMHSA were available at 1,132 facilities or 8 percent of all substance abuse treatment facilities and patients receiving methadone or buprenorphine accounted for 24 percent of all patients in treatment.

• Of the 272,351 clients receiving one of the two medications approved for the treatment of opioid addiction, 98 percent received methadone. Of the 15,732 clients receiving buprenorphine, the majority (73 percent) did not receive it from OTPs.

• Between 2004 and 2008, the proportion of clients in all facilities receiving methadone or buprenor-phine ranged from 22 percent to 24 percent.

• Most facilities with OTPs offered outpatient treatment (92.2 percent). Outpatient methadone/buprenorphine maintenance was offered in 88.7 percent, regular outpatient treatment in 62 percent, detoxification in 47.4 percent, intensive outpatient treatment in 25.7 percent, and day treatment/partial hospitalization in 8.1 percent of facilities with OTPs.

• Federal government-operated facilities (i.e., Veterans Administration, Tribal government) with OTPs were more likely than facilities of other operational structures to offer more than one type of care. One-hundred percent of the Federal government-operated facilities with OTPs offered outpatient treatment, 50 percent offered hospital inpatient treatment, and 36.1 percent offered residential (non-hospital) treatment. Ninety-four percent offered outpatient methadone/buprenorphine maintenance. Private for-profit facilities with OTPs had the lowest proportions of facilities offering residential (non-hospital) and hospital inpatient treatment at 3.8 percent and 3.2 percent respectively.

The requirement for SAMHSA’s approval of OTPs is that they be accredited by an approved accredi-tation organization. Of the OTPs, 27 percent were accredited by The Joint Commission (formerly known as Joint Commission on Accreditation of Health Care Organization-JCAHO), 66.4 percent by the Commission on Accreditation of Rehabilitation Facilities (CARF), 4.3 percent by the Council on Accreditation (COA), .9 percent by the National Commission on Correctional Health Care (NCCHC), and 1.4 percent by the State Accreditation Authority.

AlabamaThe July 1, 2009 U.S. Census Bureau population estimate for Alabama was 4,708,708 (1.5 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 13,939 patients receiving any type of substance abuse treatment in 136 facilities.

State Opioid Treatment AuthorityRobert Wynn

State Methadone AuthorityDepartment of Mental Health, Mental Retardation & Substance Abuse Services Div.P.O. Box 301410 100 North Union Street Montgomery, AL 36130-1410Phone: (334) 242-3956Fax: (334) 242-0759Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Alabama Certified Opioid Treatment Programs as of March 2010: 20


Type of Treatment in OTPs State Percent National PercentTreatment: Maintenance only 23.5 31.3Treatment: Detoxification only -- 6.6Both maintenance and detoxification 76.5 62.1

Number of Patients in OTPs State NationalTotal Number of Patients 6,671 272,351

Patients receiving methadone 6,635 268,071Patients receiving buprenorphine 36 4,280


Type of Payment Accepted for All Services by OTPs1 State Percent National PercentCash or self-payment 100.0 95.9Private health insurance 47.1 48.5Medicare 5.9 29.4Medicaid 5.9 62.8State financed insurance (other than Medicaid) 5.9 32.0Federal military insurance (e.g., VA, TRICARE) -- 17.8Sliding fee scale (based on income and other factors) 5.9 51.1No charge for patients who cannot pay 11.8 33.4

Source: SAMHSA, CBHSQ. National Survey of Substance Abuse Treatment Services (N-SSATS). March 31, 2008. 1Facilities may accept more than one type of payment.

Type of Operation of OTPs State Percent National PercentPrivate non-profit 5.9 38.9Private for-profit 94.1 49.3Local, county, or community government -- 4.6State government -- 3.8Federal government -- 3.2Tribal government -- 0.3


Accreditation of OTPs State Percent National PercentThe Joint Commission 5.0 27.0CARF (Commission on Accreditation of Rehabilitation Facilities) 95.0 66.4

COA (Council on Accreditation) -- 4.3NCCHC (National Commission on Correctional Health Care) -- 0.9

State Accreditation Authority -- 1.4


BuprenorphineAlabama DATA Certified Physicians as of March 2010: 235The following map shows the location of the physicians that have waivers in Alabama.


Cumulative Distribution of Buprenorphine Per 100,000 Population1 by Grams Weight: January 1 through December 31, 2008State National Rank

Buprenorphine 443.74 grams 288.14 grams 14

Source: U.S. Department of Justice, Drug Enforcement Administration. Automation of Reports and Consolidated Orders System (ARCOS). May 1, 2009. 1Population based on 2000 Census.

Alaska The July 1, 2009 U.S. Census Bureau population estimate for Alaska was 698,473 (0.2 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 3,026 patients receiving any type of substance abuse treatment in 71 facilities.

State Opioid Treatment AuthorityViki Wells, Behavioral Health Specialist

Behavioral Health/Treatment and Recovery SectionDept. of Health & Social Services3601 C. St., Suite 878Anchorage, AK 99503Phone: (907) 269-3794 1-800-770-3930 (in-state)Fax: (907) 269-3623Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Alaska Certified Opioid Treatment Programs as of March 2010: 2


Type of Treatment in OTPs State Percent National PercentMaintenance only -- 31.3Detoxification only -- 6.6Both maintenance and detoxification 100.0 62.1

Number of Patients in OTPs State NationalTotal 111 272,351

Patients receiving methadone 111 268,071Patients receiving buprenorphine -- 4,280


Type of Payment Accepted for All Services by OTPs1 State Percent National PercentCash or self-payment 100.0 95.9Private health insurance 100.0 48.5Medicare -- 29.4Medicaid 100.0 62.8State financed insurance (other than Medicaid) 50.0 32.0Federal military insurance (e.g., VA, TRICARE) 100.0 17.8Sliding fee scale (based on income and other factors) 100.0 51.1No charge for patients who cannot pay 50.0 33.4


Type of Operation of OTPs State Percent National PercentPrivate non-profit 100.0 38.9Private for-profit -- 49.3Local, county, or community government -- 4.6State government -- 3.8Federal government -- 3.2Tribal government -- 0.3


Accreditation of OTPs State Percent National PercentThe Joint Commission -- 27.0CARF (Commission on Accreditation of Rehabilitation Facilities) 100.0 66.4




BuprenorphineAlaska DATA Certified Physicians as of March 2010: 61The following map shows the location of the physicians that have waivers in Alaska.





Arizona The July 1, 2009 U.S. Census Bureau population estimate for Arizona was 6,595,778 (2.1 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 31,538 patients receiving any type of substance abuse treatment in 212 facilities.

State Opioid Treatment AuthorityJay McGahee Acting Program Manager

Arizona Department of Health ServicesOffice of Behavioral Health Licensing150 North 18th Avenue, Suite 410Phoenix, Arizona 85007Phone: (602) 364-2595 Fax: (602) 364-4801 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Arizona Certified Opioid Treatment Programs as of March 2010: 30


Type of Treatment in OTPs State Percent National PercentMaintenance only 38.5 31.3Detoxification only -- 6.6Both maintenance and detoxification 61.5 62.1

Number of Patients in OTPs State Percent National PercentTotal 4,109 272,351



Type of Payment Accepted for All Services by OTPs1 State Percent NationalCash or self-payment 96.2 95.9Private health insurance 19.2 48.5Medicare 42.3 29.4Medicaid 53.9 62.8State financed insurance (other than Medicaid) 61.5 32.0Federal military insurance (e.g., VA, TRICARE) 15.4 17.8Sliding fee scale (based on income and other factors) 26.9 51.1No charge for patients who cannot pay 19.2 33.4


Type of Operation of OTPs Percent (State) Percent (National)Private non-profit 26.9 38.9Private for-profit 65.4 49.3Local, county, or community government -- 4.6State government -- 3.8Federal government 3.9 3.2Tribal government 3.9 0.3


Accreditation of OTPs Percent (State) Percent (National)The Joint Commission 3.3 27.0CARF (Commission on Accreditation of Rehabilitation Facilities) 96.7 66.4




BuprenorphineArizona DATA Certified Physicians as of March 2010: 370The following map shows the location of the physicians that have waivers in Arizona.





ArkansasThe July 1, 2009 U.S. Census Bureau population estimate for Arkansas was 2,889,450 (0.9 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 4,062 patients receiving any type of substance abuse treatment in 59 facilities.

State Opioid Treatment Authority

Phillip D. Hall, Director

State Methadone AuthorityProgram Compliance and Outcomes MonitoringArkansas Department of Human Services Division of Behavioral Health Services Office of Alcohol and Drug Abuse Prevention4313 West Markham, 3rd Floor Administration Little Rock, AR 72205Phone: (501) 686-9921Fax: (501) 686-9396Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Arkansas Certified Opioid Treatment Programs as of March 2010: 3




Patients receiving methadone 352 268,071Patients receiving buprenorphine 1 4,280


Type of Payment Accepted for All Services by OTPs1 State Percent National PercentCash or self-payment 100.0 95.9Private health insurance -- 48.5Medicare -- 29.4Medicaid -- 62.8State financed insurance (other than Medicaid) -- 32.0Federal military insurance (e.g., VA, TRICARE) -- 17.8Sliding fee scale (based on income and other factors) 33.3 51.1No charge for patients who cannot pay -- 33.4


Type of Operation of OTPs State Percent National PercentPrivate non-profit -- 38.9Private for-profit 66.7 49.3Local, county, or community government -- 4.6State government 33.3 3.8Federal government -- 3.2Tribal government -- 0.3






BuprenorphineArkansas DATA Certified Physicians as of March 2010: 50The following map shows the location of the physicians that have waivers in Arkansas.





California The July 1, 2009 U.S. Census Bureau population estimate for California was 36,961,664 (12.0 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 139,339 patients receiving any type of substance abuse treatment in 1,725 facilities.


Gladys M. Mitchell, Manager

Policy and Program Support Branch Licensing and Certification Division Phone: (916) 322-4840 Fax: (916) 322-2658 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total STATE Certified Opioid Treatment Programs as of March 2010: 146


Type of Treatment in OTPs State Percent National PercentMaintenance only 7.0 31.3Detoxification only 1.6 6.6Both maintenance and detoxification 91.5 62.1

Number of Patients in OTPs State NationalTotal 28,067 272,351



Type of Payment Accepted for All Services by OTPs1 State Percent National PercentCash or self-payment 96.9 95.9Private health insurance 48.1 48.5Medicare 34.9 29.4Medicaid 70.5 62.8State financed insurance (other than Medicaid) 28.7 32.0Federal military insurance (e.g., VA, TRICARE) 18.6 17.8Sliding fee scale (based on income and other factors) 86.8 51.1No charge for patients who cannot pay 27.9 33.4


Type of Operation of OTPs State Percent National PercentPrivate non-profit 24.0 38.9Private for-profit 64.3 49.3Local, county, or community government 5.4 4.6State government 1.6 3.8Federal government 4.7 3.2Tribal government -- 0.3



COA (Council on Accreditation) 21.2 4.3NCCHC (National Commission on Correctional Health Care) 0.7 0.9



BuprenorphineCalifornia DATA Certified Physicians as of March 2010: 2,087The following map shows the location of the physicians that have waivers in California.




Source: U.S. Department of Justice, Drug Enforcement Administration. Automation of Reports and Consolidated Orders System (ARCOS). May 1, 2009. 1 Population based on 2000 Census.

ColoradoThe July 1, 2009 U.S. Census Bureau population estimate for Colorado was 5,024,748 (1.6 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 36,059 patients receiving any type of substance abuse treatment in 436 facilities.


Daria Leslea, Controlled Substance Administrator

Colorado Department of Human ServicesDivision of Behavioral Health3824 W. Princeton CircleDenver, CO 80236Phone: (303) 866-7493Fax: (303) 866-7520Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Colorado Certified Opioid Treatment Programs as of March 2010: 11








Type of Operation of OTPs State Percent National PercentPrivate non-profit 11.1 38.9Private for-profit 33.3 49.3Local, county, or community government -- 4.6State government 55.6 3.8Federal government -- 3.2Tribal government -- 0.3






BuprenorphineColorado DATA Certified Physicians as of March 2010: 228The following map shows the location of the physicians that have waivers in Colorado.





Connecticut The July 1, 2009 U.S. Census Bureau population estimate for Connecticut was 3,518,288 (1.1 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 25,902 patients receiving any type of substance abuse treatment in 203 facilities.


Lauren Siembab

Department of Mental Health and Addiction Services410 Capitol Avenue, MS#14HCS, 4th FloorHartford, Connecticut 06134Phone: (860) 418-6897Fax: (860) 418-6691E-mail: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Connecticut Certified Opioid Treatment Programs as of March 2010: 35








Type of Operation of OTPs State Percent National PercentPrivate non-profit 81.1 38.9Private for-profit 5.4 49.3Local, county, or community government -- 4.6State government 10.8 3.8Federal government 2.7 3.2Tribal government -- 0.3



COA (Council on Accreditation) -- 4.3NCCHC (National Commission on Correctional Health Care) 2.9 0.9



BuprenorphineConnecticut DATA Certified Physicians as of March 2010: 358The following map shows the location of the physicians that have waivers in Connecticut.





Delaware The July 1, 2009 U.S. Census Bureau population estimate for Delaware was 885,122 (0.3 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 4,106 patients receiving any type of substance abuse treatment in 39 facilities.


Steven Dettwyler, Ph.D. Director

Division of Substance Abuse and Mental Health1901 N. DuPont HighwayNew Castle DE 19720Tel: 302-255-9432 Fax: 302-255-4428 E-mail: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Delaware Certified Opioid Treatment Programs as of March 2010: 6














BuprenorphineDelaware DATA Certified Physicians as of March 2010: 48The following map shows the location of the physicians that have waivers in Delaware.





District of ColumbiaThe July 1, 2009 U.S. Census Bureau population estimate for the District of Columbia was 599,657 (0.2 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 4,498 patients receiving any type of substance abuse treatment in 44 facilities.


Roula K. Sweis, M.A., Psy.D.

Addiction Prevention & Recovery Administration1300 1st., N.E.Washington, DC 20002Office: (202)727-8940Cell: (202) 236-7129Fax: (202) 727-0092 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total District of Columbia Certified Opioid Treatment Programs as of March 2010: 7














BuprenorphineDistrict of Columbia DATA Certified Physicians as of March 2010: 80The following map shows the location of the physicians that have waivers in the District of Columbia.





Florida The July 1, 2009 U.S. Census Bureau population estimate for Florida was 18,537,969 (6.0 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 53,165 patients receiving any type of substance abuse treatment in 644 facilities.


Darran Duchene

State Methadone Authority Director, Treatment Services Substance Abuse Program Office 1317 Winewood Boulevard Building 6, Room 334 Tallahassee, FL 32399-0700 Phone: (850) 921-8464 Fax: (850) 414-7474 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Florida Certified Opioid Treatment Programs as of March 2010: 41














BuprenorphineFlorida DATA Certified Physicians as of March 2010: 1,148The following map shows the location of the physicians that have waivers in Florida.





Georgia The July 1, 2009 U.S. Census Bureau population estimate for Georgia was 9,829,211 (3.2 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 19,206 patients receiving any type of substance abuse treatment in 265 facilities.


Vonshurii S. Wrighten, M.Div., MAC, CCS, SAP

Adult Program Specialist Division of Addictive Diseases Georgia Department of Behavioral Health & Developmental Disabilities 2 Peachtree Street, NW, Ste. 22-283 Atlanta, GA 30303-3142 Phone: (404) 657-2386 Fax: (404) 657-6417 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Georgia Certified Opioid Treatment Programs as of March 2010: 45








Type of Operation of OTPs State Percent National PercentPrivate non-profit 3.0 38.9Private for-profit 90.9 49.3Local, county, or community government 3.0 4.6State government -- 3.8Federal government 3.0 3.2Tribal government -- 0.3






BuprenorphineGeorgia DATA Certified Physicians as of March 2010: 465The following map shows the location of the physicians that have waivers in Georgia.





Hawaii The July 1, 2009 U.S. Census Bureau population estimate for Hawaii was 1,295,178 (0.4 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 4,275 patients receiving any type of substance abuse treatment in 123 facilities.


Jared Yurow, Psy.D.

Hawaii Licensed Psychologist Clinical Psychologist VII (Administrative) Community & Consultative Services Branch Alcohol & Drug Abuse Division Hawaii State Dept. Health Kakuhihewa Bldg. 601 Kamokila Blvd. Room 360 Kapolei, HI 96707 Phone: (808) 692-7509 Fax: (808) 692-7521Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Hawaii Certified Opioid Treatment Programs as of March 2010: 4














BuprenorphineHawaii DATA Certified Physicians as of March 2010: 82The following map shows the location of the physicians that have waivers in Hawaii.





Idaho The July 1, 2009 U.S. Census Bureau population estimate for Idaho was 1,545,801 (0.5 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 3,772 patients receiving any type of substance abuse treatment in 77 facilities.


Ryan Phillips, Program Specialist

Division of Behavioral Health Idaho Dept. of Health and Welfare Tel: 208.334.6610 Fax: 208.334.0667 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Idaho Certified Opioid Treatment Programs as of March 2010: 2






BuprenorphineIdaho DATA Certified Physicians as of March 2010: 33The following map shows the location of the physicians that have waivers in Idaho.





Illinois The July 1, 2009 U.S. Census Bureau population estimate for Illinois was 12,910,409 (4.2 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 43,889 patients receiving any type of substance abuse treatment in 608 facilities


Richard Weisskopf

State Methadone AuthorityDepartment of Human ServicesDivision of Alcoholism and Substance Abuse100 W. Randolph Street, Suite 5-600Chicago, IL 60601-3297Phone: (312) 814-6380Fax: (312) 814-2419Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Illinois Certified Opioid Treatment Programs as of March 2010: 64














BuprenorphineIllinois DATA Certified Physicians as of March 2010: 455The following map shows the location of the physicians that have waivers in Illinois.





Indiana The July 1, 2009 U.S. Census Bureau population estimate for Indiana was 6,423,113 (2.1 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 30,265 patients receiving any type of substance abuse treatment in 313 facilities.


Gina Eckart, Director

Office of Addiction and Emergency ServicesDivision of Mental Health and AddictionIN Family & Social Services Administration402 W. Washington St., Room W353Indianapolis, IN 46204-2739Tel: (317) 232-7860 (direct line) (317) 232-7800Fax: (317) 233-3472E-mail: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Indiana Certified Opioid Treatment Programs as of March 2010: 15














BuprenorphineIndiana DATA Certified Physicians as of March 2010: 245The following map shows the location of the physicians that have waivers in Indiana.





Iowa The July 1, 2009 U.S. Census Bureau population estimate for Iowa was 3,007,856 (1.0 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 7,071 patients receiving any type of substance abuse treatment in 113 facilities.


DeAnn Decker, Bureau Chief

Iowa Department of Public HealthBureau of Substance Abuse321 E. 12th StreetDes Moines, IA 50319Phone: 515-281-0928Fax: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Iowa Certified Opioid Treatment Programs as of March 2010: 4






Type of Payment Accepted for All Services by OTPs1 State Percent National PercentCash or self-payment 100.0 95.9Private health insurance 75.0 48.5Medicare 25.0 29.4Medicaid 25.0 62.8State financed insurance (other than Medicaid) 25.0 32.0Federal military insurance (e.g., VA, TRICARE) 50.0 17.8Sliding fee scale (based on income and other factors) 25.0 51.1No charge for patients who cannot pay -- 33.4








BuprenorphineIowa DATA Certified Physicians as of March 2010: 40The following map shows the location of the physicians that have waivers in Iowa.





Kansas The July 1, 2009 U.S. Census Bureau population estimate for Kansas was 2,818,747 (0.9 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 10,855 patients receiving any type of substance abuse treatment in 221 facilities.


Stacy R. Chamberlain, M.A. Clinical Services Coordinator

State of Kansas Department of SRS Disability and Behavioral Health Services Addiction and Prevention Services 915 SW Harrison, 9th Floor South Topeka, KS 66612 Phone: (785) 296-0649 Fax: (785) 296-7275 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Kansas Certified Opioid Treatment Programs as of March 2010: 6














BuprenorphineKansas DATA Certified Physicians as of March 2010: 70The following map shows the location of the physicians that have waivers in Kansas.





Kentucky The July 1, 2009 U.S. Census Bureau population estimate for Kentucky was 4,314,113 (1.4 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 19,465 patients receiving any type of substance abuse treatment in 301 facilities.


Anita Jennings, Acting Director

Developmental and Intellectual Disabilities 100 Fair Oaks Lane 4E-D Frankfort, Kentucky 40621 Tel: (502) 564-4456 ext. 4523Fax: (502) 564-9010 E-mail: [email protected]

Profile of Opioid Treatment Programs (OTPs) Total Kentucky Certified Opioid Treatment Programs as of March 2010: 11






Type of Payment Accepted for All Services by OTPs1 State Percent National PercentCash or self-payment 90.0 95.9Private health insurance 20.0 48.5Medicare 20.0 29.4Medicaid 10.0 62.8State financed insurance (other than Medicaid) -- 32.0Federal military insurance (e.g., VA, TRICARE) -- 17.8Sliding fee scale (based on income and other factors) 10.0 51.1No charge for patients who cannot pay 10.0 33.4


Type of Operation of OTPs State Percent National PercentPrivate non-profit 10.0 38.9Private for-profit 70.0 49.3Local, county, or community government 10.0 4.6State government 10.0 3.8Federal government -- 3.2Tribal government -- 0.3






BuprenorphineKentucky DATA Certified Physicians as of March 2010: 226The following map shows the location of the physicians that have waivers in Kentucky.





Louisiana The July 1, 2009 U.S. Census Bureau population estimate for Louisiana was 4,492,076 (1.5 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 12,319 patients receiving any type of substance abuse treatment in 166 facilities.


Brenda Lands

Department of Health and HospitalsOffice for Addictive Disorders628 North 4th StreetBaton Rouge, LA 70802Phone: (225) 342 8735Fax: (225) 342 3931Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Louisiana Certified Opioid Treatment Programs as of March 2010: 8






Type of Payment Accepted for All Services by OTPs1 State Percent National PercentCash or self-payment 100.0 95.9Private health insurance 25.0 48.5Medicare -- 29.4Medicaid -- 62.8State financed insurance (other than Medicaid) -- 32.0Federal military insurance (e.g., VA, TRICARE) -- 17.8Sliding fee scale (based on income and other factors) 12.5 51.1No charge for patients who cannot pay 25.0 33.4


Type of Operation of OTPs State Percent National PercentPrivate non-profit -- 38.9Private for-profit 100.0 49.3Local, county, or community government -- 4.6State government -- 3.8Federal government -- 3.2Tribal government -- 0.3






BuprenorphineLouisiana DATA Certified Physicians as of March 2010: 286The following map shows the location of the physicians that have waivers in Louisiana.


Cumulative Distribution of Buprenorphine Per 100,000 Population1 by Grams Weight: January 1 through December 31, 2008 State National Rank



Maine The July 1, 2009 U.S. Census Bureau population estimate for Maine was 1,318,301 (0.4 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 10,465 patients receiving any type of substance abuse treatment in 188 facilities.


Kristen Jiorle Acting OSA Treatment Manager

Maine Office of Substance Abuse 11 State House Station Augusta, ME 04333-0011 Tel: 207-287-2297 Fax: 207-287-4345 E-mail: [email protected]

Profile of Opioid Treatment Programs (OTPs) Total Maine Certified Opioid Treatment Programs as of March 2010: 10






Type of Payment Accepted for All Services by OTPs1 State Percent National PercentCash or self-payment 100.0 95.9Private health insurance 33.3 48.5Medicare 33.3 29.4Medicaid 100.0 62.8State financed insurance (other than Medicaid) -- 32.0Federal military insurance (e.g., VA, TRICARE) 22.2 17.8Sliding fee scale (based on income and other factors) 11.1 51.1No charge for patients who cannot pay 22.2 33.4








BuprenorphineMaine DATA Certified Physicians as of March 2010: 238The following map shows the location of the physicians that have waivers in Maine.



Buprenorphine 1,193.23 grams 288.14 grams 2


Maryland The July 1, 2009 U.S. Census Bureau population estimate for Maryland was 5,699,478 (1.9 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 35,658 patients receiving any type of substance abuse treatment in 371 facilities.


Peter R. Cohen, MD Medical Director

Maryland Alcohol & Drug Abuse Administration 55 Wade Avenue Catonsville, MD 21228 Tel: (410) 402-8677 Fax: (410) 402-8601 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Maryland Certified Opioid Treatment Programs as of March 2010: 59














BuprenorphineMaryland DATA Certified Physicians as of March 2010: 719The following map shows the location of the physicians that have waivers in Maryland.





Massachusetts The July 1, 2009 U.S. Census Bureau population estimate for Massachusetts was 6,593,587 (2.1 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 40,604 patients receiving any type of substance abuse treatment in 316 facilities.


Hilary Jacobs, LICSW, LADC I

State Methadone Authority Acting Deputy Director Bureau of Substance Abuse Services Massachusetts Department of Public Health 250 Washington Street, Third Floor Boston, MA 02108-4619 Telephone: 617-624-5188 Fax: 617-624-5395 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Massachusetts Certified Opioid Treatment Programs as of March 2010: 51











COA (Council on Accreditation) 2.0 4.3NCCHC (National Commission on Correctional Health Care) -- 0.9



BuprenorphineMassachusetts DATA Certified Physicians as of March 2010: 850The following map shows the location of the physicians that have waivers in Massachusetts.





Michigan The July 1, 2009 U.S. Census Bureau population estimate for Michigan was 9,969,727 (3.2 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 47,010 patients receiving any type of substance abuse treatment in 512 facilities.


Jeffery Wieferich, Acting SOTA Treatment Services Manager

Office of Drug Control Policy Michigan Department of Community Health 320 South Walnut Street Lansing, MI 48913 Tel: (517) 335-0499 Fax: (517) 335-2121 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Michigan Certified Opioid Treatment Programs as of March 2010: 33














BuprenorphineMichigan DATA Certified Physicians as of March 2010: 825The following map shows the location of the physicians that have waivers in Michigan.





Minnesota The July 1, 2009 U.S. Census Bureau population estimate for Minnesota was 5,266,214 (1.7 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 16,319 patients receiving any type of substance abuse treatment in 286 facilities.


Richard A. Moldenhauer, MS, LADC

State Methadone Authority Chemical Health Division PO Box 64977 St. Paul, MN 55164-0977 Phone: (651) 431-2474 Fax: (651) 431-7449 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Minnesota Certified Opioid Treatment Programs as of March 2010: 14














BuprenorphineMinnesota DATA Certified Physicians as of March 2010: 159The following map shows the location of the physicians that have waivers in Minnesota.





Mississippi The July 1, 2009 U.S. Census Bureau population estimate for Mississippi was 2,951,996 (1.0 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 5,001 patients receiving any type of substance abuse treatment in 102 facilities.


Herbert L. Loving, Director

Bureau of Alcohol & Drug Abuse Department of Mental Health Robert E. Lee State Office Bldg., 11th Floor 239 N. Lamar Street Jackson, MS 39201 Phone: (601) 359-1288 Fax: (601) 359-6295 E-mail: [email protected] cc: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Mississippi Certified Opioid Treatment Programs as of March 2010: 1






Type of Payment Accepted for All Services by OTPs1 State Percent National PercentCash or self-payment 100.0 95.9Private health insurance -- 48.5Medicare -- 29.4Medicaid -- 62.8State financed insurance (other than Medicaid) -- 32.0Federal military insurance (e.g., VA, TRICARE) -- 17.8Sliding fee scale (based on income and other factors) -- 51.1No charge for patients who cannot pay -- 33.4








BuprenorphineMississippi DATA Certified Physicians as of March 2010: 146The following map shows the location of the physicians that have waivers in Mississippi.





Missouri The July 1, 2009 U.S. Census Bureau population estimate for Missouri was 5,987,580 (2.0 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 19,610 patients receiving any type of substance abuse treatment in 257 facilities.


Cheryl Marcum Program Specialist II

Missouri Department of Mental Health/Division of Alcohol and Drug Abuse 1706 E. Elm PO Box 687 Jefferson City, MO 65101Phone: 573-526-4507Fax: 573-751-7814Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Missouri Certified Opioid Treatment Programs as of March 2010: 11












State Accreditation Authority 45.5 1.4


BuprenorphineMissouri DATA Certified Physicians as of March 2010: 184The following map shows the location of the physicians that have waivers in Missouri.





Montana The July 1, 2009 U.S. Census Bureau population estimate for Montana was 974,989 (0.3 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 2,996 patients receiving any type of substance abuse treatment in 63 facilities.


Jackie Jandt Planning & Outcome Officer

Addictive & Mental Disorders Division 555 Fuller Ave/PO Box 202905 Helena MT 59620-2905 Phone: 406-444-9656 Cell: 406-431-7157 Fax: 406-444-9389 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs) Total Montana Certified Opioid Treatment Programs as of March 2010: 1


Accreditation of OTPs State Percent National PercentThe Joint Commission 100.0 27.0CARF (Commission on Accreditation of Rehabilitation Facilities) -- 66.4




BuprenorphineMontana DATA Certified Physicians as of March 2010: 34The following map shows the location of the physicians that have waivers in Montana.





Nebraska The July 1, 2009 U.S. Census Bureau population estimate for Nebraska was 1,796,619 (0.6 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 4,943 patients receiving any type of substance abuse treatment in 114 facilities.


Blaine Shaffer, MD Chief Clinical Officer

Department of Health and Human Services, Division of Behavioral Health301 Centennial Mall SouthLincoln, NE 68509Phone: (402)471-7795, Fax: (402)471-7859 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Nebraska Certified Opioid Treatment Programs as of March 2010: 3






Type of Payment Accepted for All Services by OTPs1 State Percent National PercentCash or self-payment 100.0 95.9Private health insurance -- 48.5Medicare -- 29.4Medicaid -- 62.8State financed insurance (other than Medicaid) -- 32.0Federal military insurance (e.g., VA, TRICARE) -- 17.8Sliding fee scale (based on income and other factors) -- 51.1No charge for patients who cannot pay -- 33.4




Accreditation of OTPs State Percent National PercentThe Joint Commission -- 27.0CARF (Commission on Accreditation of Rehabilitation Facilities) 100.0% 66.4




BuprenorphineNebraska DATA Certified Physicians as of March 2010: 42The following map shows the location of the physicians that have waivers in Nebraska.





Nevada The July 1, 2009 U.S. Census Bureau population estimate for Nevada was 2,643,085 (0.9 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 13,327 patients receiving any type of substance abuse treatment in 77 facilities.


Patricia Chambers, RN, BSN, HFS III

Nevada State Health DivisionBureau of Licensure and Certification1550 College Parkway, Suite 158Carson City, NV 89706Phone: 775-687-4475 ext 234Fax: 775-687-6588 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Nevada Certified Opioid Treatment Programs as of March 2010: 12


Type of Treatment in OTPs State Percent National PercentMaintenance only -- 31.3Detoxification only 11.1 6.6Both maintenance and detoxification 88.9 62.1




Type of Payment Accepted for All Services by OTPs1 State Percent National PercentCash or self-payment 100.0 95.9Private health insurance 55.6 48.5Medicare 11.1 29.4Medicaid 77.8 62.8State financed insurance (other than Medicaid) -- 32.0Federal military insurance (e.g., VA, TRICARE) -- 17.8Sliding fee scale (based on income and other factors) 33.3 51.1No charge for patients who cannot pay 33.3 33.4








BuprenorphineNevada DATA Certified Physicians as of March 2010: 160The following map shows the location of the physicians that have waivers in Nevada.





New Hampshire The July 1, 2009 U.S. Census Bureau population estimate for New Hampshire was 1,324,575 (0.4 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 4,950 patients receiving any type of substance abuse treatment in 61 facilities.


Joe Harding, AOD Policy Office

State Methadone Authority105 Pleasant StreetConcord, NH 03301Phone: (603) 271-8554Fax: (603) 271-6105Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total New Hampshire Certified Opioid Treatment Programs as of March 2010: 8




Patients receiving methadone 1,692 268,071Patients receiving buprenorphine -- 4,280


Type of Payment Accepted for All Services by OTPs1 State Percent National PercentCash or self-payment 100.0 95.9Private health insurance 44.4 48.5Medicare 22.2 29.4Medicaid 88.9 62.8State financed insurance (other than Medicaid) 22.2 32.0Federal military insurance (e.g., VA, TRICARE) 11.1 17.8Sliding fee scale (based on income and other factors) -- 51.1No charge for patients who cannot pay -- 33.4








BuprenorphineNew Hampshire DATA Certified Physicians as of March 2010: 72The following map shows the location of the physicians that have waivers in New Hampshire.





New Jersey The July 1, 2009 U.S. Census Bureau population estimate for New Jersey was 8,707,739 (2.8 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 30,416 patients receiving any type of substance abuse treatment in 331 facilities.


Raquel Mazon Jeffers, Director

NJ Department of Human Services Division of Addiction Services PO Box 362 120 South Stockton Street Trenton, NJ 08625 Phone: (609) 292-5760 Fax: (609) 292-3816 Email: [email protected] Cc: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total New Jersey Certified Opioid Treatment Programs as of March 2010: 35














BuprenorphineNew Jersey DATA Certified Physicians as of March 2010: 783The following map shows the location of the physicians that have waivers in New Jersey.





New Mexico The July 1, 2009 U.S. Census Bureau population estimate for New Mexico was 2,009,671 (0.7 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 13,719 patients receiving any type of substance abuse treatment in 145 facilities.


Jay Crowe Social and Community Services Coordinator

Behavioral health Services DivisionMailing Address: P.O. Box 2348 Santa Fe NM 87504Street Address: 37 Plaza la Prensa Santa Fe, NM 87507Phone: (505) 476-9267Fax: (505) 476-9277Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total New Mexico Certified Opioid Treatment Programs as of March 2010: 8














BuprenorphineNew Mexico DATA Certified Physicians as of March 2010: 254The following map shows the location of the physicians that have waivers in New Mexico.





New York The July 1, 2009 U.S. Census Bureau population estimate for New York was 19,541,453 (6.4 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 115,662 patients receiving any type of substance abuse treatment in 964 facilities.


Belinda Greenfield

State Opioid Treatment AuthorityNew York State Office of Alcoholism and Substance Abuse Services501 7th AvenueNew York, New York 10018-5903Phone: (646) 728-4581Fax: (646) 728-4690Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total New York Certified Opioid Treatment Programs as of March 2010: 152














BuprenorphineNew York DATA Certified Physicians as of March 2010: 2,096The following map shows the location of the physicians that have waivers in New York.





North Carolina The July 1, 2009 U.S. Census Bureau population estimate for North Carolina was 9,380,884 (3.1 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 30,333 patients receiving any type of substance abuse treatment in 410 facilities.


Marie Britt, RN, BSN, BC, MS

Division of MH/DD/SAS Best Practices Team3005 Mail Service CenterRaleigh, NC 27699-3005Phone: 919-715-2774 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total North Carolina Certified Opioid Treatment Programs as of March 2010: 42








Type of Operation of OTPs State Percent National PercentPrivate non-profit 48.6 38.9Private for-profit 42.9 49.3Local, county, or community government -- 4.6State government 8.6 3.8Federal government -- 3.2Tribal government -- 0.3






BuprenorphineNorth Carolina DATA Certified Physicians as of March 2010: 320The following map shows the location of the physicians that have waivers in North Carolina.





North Dakota The July 1, 2009 U.S. Census Bureau population estimate for North Dakota was 646,844 (0.2 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 2,123 patients receiving any type of substance abuse treatment in 64 facilities. There currently are no certified facilities that offer OTPs in North Dakota.

BuprenorphineNorth Dakota DATA Certified Physicians as of March 2010: 16The following map shows the location of the physicians that have waivers in North Dakota.





Ohio The July 1, 2009 U.S. Census Bureau population estimate for Ohio was 11,542,645 (3.8 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 36,743 patients receiving any type of substance abuse treatment in 402 facilities.


Bradley M. DeCamp, MPA Assistant Chief

Division of Treatment and Recovery ServicesOhio Dept of Alcohol and Drug Addiction Services 280 N. High St., 15th Floor Columbus, OH 43215 Tel: 614-752-8363 Fax: 614-752-8645 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Ohio Certified Opioid Treatment Programs as of March 2010: 16














BuprenorphineOhio DATA Certified Physicians as of March 2010: 510The following map shows the location of the physicians that have waivers in Ohio.





Oklahoma The July 1, 2009 U.S. Census Bureau population estimate for Oklahoma was 3,687,050 (1.2 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 11,099 patients receiving any type of substance abuse treatment in 186 facilities.


Ray Caesar

Dept. of Mental Health and Substance Abuse Services Shepherd Mall 2401 N.W. 23rd Street, Suite 82 Oklahoma City, Oklahoma 73107-2431 Phone: (405) 522-3870 Fax: (405) 522-4470 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Oklahoma Certified Opioid Treatment Programs as of March 2010: 15








Type of Operation of OTPs State Percent National PercentPrivate non-profit -- 38.9Private for-profit 80.0 49.3Local, county, or community government -- 4.6State government -- 3.8Federal government 10.0 3.2Tribal government 10.0 0.3






BuprenorphineOklahoma DATA Certified Physicians as of March 2010: 114The following map shows the location of the physicians that have waivers in Oklahoma.





Oregon The July 1, 2009 U.S. Census Bureau population estimate for Oregon was 3,825,657 (1.2 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 23,558 patients receiving any type of substance abuse treatment in 237 facilities.


Therese Hutchinson Policy and Program Development Specialist

Intensive Treatment and Recovery Services Coordinator State Methadone Authority Addictions and Mental Health Division (AMH) Phone: (503) 945-5765 Fax: (503) 947-5043 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Oregon Certified Opioid Treatment Programs as of March 2010: 14














BuprenorphineOregon DATA Certified Physicians as of March 2010: 222The following map shows the location of the physicians that have waivers in Oregon.





Pennsylvania The July 1, 2009 U.S. Census Bureau population estimate for Pennsylvania was 12,604,767 (4.1 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 50,579 patients receiving any type of substance abuse treatment in 551 facilities.


Cheryl Williams

Pennsylvania Department of Health Division of Drug and Alcohol Program Licensure 132 Kline Plaza, Suite A Harrisburg, PA 17104 Phone: (717) 783-8675 Fax: (717) 787-3188 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Pennsylvania Certified Opioid Treatment Programs as of March 2010: 65








Type of Operation of OTPs State Percent National PercentPrivate non-profit 50.8 38.9Private for-profit 44.3 49.3Local, county, or community government -- 4.6State government -- 3.8Federal government 4.9 3.2Tribal government -- 0.3






BuprenorphinePennsylvania DATA Certified Physicians as of March 2010: 1,165The following map shows the location of the physicians that have waivers in Pennsylvania.





Rhode Island The July 1, 2009 U.S. Census Bureau population estimate for Rhode Island was 1,053,209 (0.3 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 7,813 patients receiving any type of substance abuse treatment in 53 facilities.


Rebecca Boss

Department of Mental Health, Retardation & Hospitals Division of Behavioral Healthcare 14 Harrington Rd., Barry Hall Bldg. #52 Cranston, RI 02920-3080 Phone: (401) 462-0723 Fax: (401) 462-6078 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Rhode Island Certified Opioid Treatment Programs as of March 2010: 18








Type of Operation of OTPs State Percent National PercentPrivate non-profit 41.2 38.9Private for-profit 52.9 49.3Local, county, or community government -- 4.6State government -- 3.8Federal government 5.9 3.2Tribal government -- 0.3






BuprenorphineRhode Island DATA Certified Physicians as of March 2010: 126The following map shows the location of the physicians that have waivers in Rhode Island.





South Carolina The July 1, 2009 U.S. Census Bureau population estimate for South Carolina was 4,561,242 (1.5 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 14,986 patients receiving any type of substance abuse treatment in 111 facilities.


Virginia Ervin, B.S.N., CARN, COHN

State Methadone Authority South Carolina Department of Alcohol and Other Drugs 101 Executive Center Drive, Suite 215 Columbia, SC 29201 Phone: (803) 896-4860 Fax: (803) 896-5984 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total South Carolina Certified Opioid Treatment Programs as of March 2010: 12






Type of Payment Accepted for All Services by OTPs1 State Percent National PercentCash or self-payment 100.0 95.9Private health insurance 10.0 48.5Medicare 10.0 29.4Medicaid -- 62.8State financed insurance (other than Medicaid) 10.0 32.0Federal military insurance (e.g., VA, TRICARE) -- 17.8Sliding fee scale (based on income and other factors) -- 51.1No charge for patients who cannot pay 20.0 33.4


Type of Operation of OTPs State Percent National PercentPrivate non-profit 10.0 38.9Private for-profit 80.0 49.3Local, county, or community government 10.0 4.6State government -- 3.8Federal government -- 3.2Tribal government -- 0.3






BuprenorphineSouth Carolina DATA Certified Physicians as of March 2010: 177The following map shows the location of the physicians that have waivers in South Carolina.





South Dakota The July 1, 2009 U.S. Census Bureau population estimate for South Dakota was 812,383 (0.3 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 2,886 patients receiving any type of substance abuse treatment in 64 facilities. There currently are no certified facilities that offer OTPs in South Dakota.

BuprenorphineSouth Dakota DATA Certified Physicians as of March 2010: 13The following map shows the location of the physicians that have waivers in South Dakota.





Tennessee The July 1, 2009 U.S. Census Bureau population estimate for Tennessee was 6,296,254 (2.1 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 12,989 patients receiving any type of substance abuse treatment in 197 facilities.


Jason Carter, PharmD Chief of Pharmacy

State Methadone Authority Cordell Hull Bldg. 5th Floor 425 Fifth Avenue North Nashville, TN 37243 Phone: 615-532-6736 Fax: 615-253-5182 or 615-741-6602 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Tennessee Certified Opioid Treatment Programs as of March 2010: 10






Type of Payment Accepted for All Services by OTPs1 State Percent National PercentCash or self-payment 100.0 95.9Private health insurance 12.5 48.5Medicare -- 29.4Medicaid -- 62.8State financed insurance (other than Medicaid) -- 32.0Federal military insurance (e.g., VA, TRICARE) -- 17.8Sliding fee scale (based on income and other factors) -- 51.1No charge for patients who cannot pay -- 33.4








BuprenorphineTennessee DATA Certified Physicians as of March 2010: 316The following map shows the location of the physicians that have waivers in Tennessee.





Texas The July 1, 2009 U.S. Census Bureau population estimate for Texas was 24,782,302 (8.1 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 49,241 patients receiving any type of substance abuse treatment in 480 facilities.


Christine Ramirez

State Methadone Authority Texas Department of State Health Services Substance Abuse Compliance Group Mail Code 1979, P.O. Box 149347 Austin, Texas 78714-9347Phone: 512.834.6700 x-2146 Fax: 512.834.6638Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Texas Certified Opioid Treatment Programs as of March 2010: 78














BuprenorphineTexas DATA Certified Physicians as of March 2010: 945The following map shows the location of the physicians that have waivers in Texas.





Utah The July 1, 2009 U.S. Census Bureau population estimate for Utah was 2,784,572 (0.9 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 12,792 patients receiving any type of substance abuse treatment in 146 facilities.


Dave Felt, LCSW Treatment Program Administrator

State Division of Substance Abuse & Mental Health120 N. 200 W., Suite 209Salt Lake City, UT 84103 Office: (801)538-4379Fax: (801)538-9892Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Utah Certified Opioid Treatment Programs as of March 2010: 10














BuprenorphineUtah DATA Certified Physicians as of March 2010: 229The following map shows the location of the physicians that have waivers in Utah.





Vermont The July 1, 2009 U.S. Census Bureau population estimate for Vermont was 621,760 (0.2 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 4,648 patients receiving any type of substance abuse treatment in 45 facilities.


Richard Keane Substance Abuse Program Coordinator

Vermont Department of Health, Division of Alcohol and Drug Abuse Programs108 Cherry Street, Burlington, VT 05402 Phone: 802-863-7651 Fax: 802-651-1573. Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Vermont Certified Opioid Treatment Programs as of March 2010: 7














Buprenorphine Vermont DATA Certified Physicians as of March 2010: 160 The following map shows the location of the physicians that have waivers in Vermont.



Buprenorphine 1,450.29 grams 288.14 grams 1


Virginia The July 1, 2009 U.S. Census Bureau population estimate for Virginia was 7,882,590 (2.6 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 20,683 patients receiving any type of substance abuse treatment in 199 facilities.


Wayde Glover

Department of Behavioral Health and Developmental Services1220 Bank StreetP.O. Box 1797Richmond, Virginia 23218Phone: (804) 371-2154Fax: (804) 786-9248Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Virginia Certified Opioid Treatment Programs as of March 2010: 20














BuprenorphineVirginia DATA Certified Physicians as of March 2010: 299The following map shows the location of the physicians that have waivers in Virginia.





Washington The July 1, 2009 U.S. Census Bureau population estimate for Washington was 6,664,195 (2.2 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 43,438 patients receiving any type of substance abuse treatment in 435 facilities.


Dennis Malmer

Division of Alcohol and Substance Abuse P.O. Box 45330Olympia, Washington 98504-5330Phone: (360) 725-3747Fax: (360) 438-8057Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Washington Certified Opioid Treatment Programs as of March 2010: 20








Type of Operation of OTPs State Percent National PercentPrivate non-profit 52.6 38.9Private for-profit 21.1 49.3Local, county, or community government 10.5 4.6State government -- 3.8Federal government 10.5 3.2Tribal government 5.3 0.3




State Accreditation Authority 60.0 1.4


BuprenorphineWashington DATA Certified Physicians as of March 2010: 399The following map shows the location of the physicians that have waivers in Washington.





West Virginia The July 1, 2009 U.S. Census Bureau population estimate for West Virginia was 1,819,777 (0.6 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 8,597 patients receiving any type of substance abuse treatment in 79 facilities.


Merritt Moore Adult Treatment Services Coordinator

Bureau for Behavioral Health and Health Facilities Division on Alcoholism and Drug Abuse 350 Capitol Street, Room 350 Charleston, WV 25301-3702 Phone: (304) 558-3847 Fax: (304) 558-1008 or 3275 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total West Virginia Certified Opioid Treatment Programs as of March 2010: 9



Number of Patients in OTPs State PercentTotal 4,125 272,351



Type of Payment Accepted for All Services by OTPs1 State Percent National PercentCash or self-payment 100.0 95.9Private health insurance 87.5 48.5Medicare -- 29.4Medicaid -- 62.8State financed insurance (other than Medicaid) -- 32.0Federal military insurance (e.g., VA, TRICARE) 12.5 17.8Sliding fee scale (based on income and other factors) 62.5 51.1No charge for patients who cannot pay 12.5 33.4








BuprenorphineWest Virginia DATA Certified Physicians as of March 2010: 154The following map shows the location of the physicians that have waivers in West Virginia.





Wisconsin The July 1, 2009 U.S. Census Bureau population estimate for Wisconsin was 5,654,774 (1.8 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 16,427 patients receiving any type of substance abuse treatment in 271 facilities.


Tanya Bakker, MS

State Opioid Treatment AuthorityBureau of Prevention Treatment and RecoveryDivision of Mental Health and Substance Abuse ServicesDepartment of Health Services 1 W. Wilson Street, Room 850Madison, WI 53702 Tel: (608) 267-7707Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total Wisconsin Certified Opioid Treatment Programs as of March 2010: 15














BuprenorphineWisconsin DATA Certified Physicians as of March 2010: 262The following map shows the location of the physicians that have waivers in Wisconsin.





Wyoming The July 1, 2009 U.S. Census Bureau population estimate for Wyoming was 544,270 (0.2 percent of the total U.S. population). On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 2,678 patients receiving any type of substance abuse treatment in 56 facilities. There currently are no certified facilities that offer OTPs in Wyoming.

BuprenorphineWyoming DATA Certified Physicians as of March 2010: 23The following map shows the location of the physicians that have waivers in Wyoming.





Guam The 2009 midyear U.S. Census Bureau population estimate for Guam was 178,000. On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 126 patients receiving any type of substance abuse treatment in 4 facilities. There currently are no certified facilities that offer OTPs in Guam.

BuprenorphineGuam DATA Certified Physicians as of March 2010: 1The following map shows the location of the physicians that have waivers in Guam.





Puerto Rico The July 1, 2009 U.S. Census Bureau population estimate for Puerto Rico was 3,967,288. On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 13,203 patients receiving any type of substance abuse treatment in 151 facilities.


Victor A. Toraño, MD

P.R. Mental Health and Anti-Addiction Services Administration P. O. Box 21414, Rio Piedras Station San Juan, PR 00928-1414 Tel: (787) 763-7575 ext. 2370 Fax: (787) 765-7104 Email: [email protected]

Profile of Opioid Treatment Programs (OTPs) Total Puerto Rico Certified Opioid Treatment Programs as of March 2010: 6






Type of Payment Accepted for All Services by OTPs1 State Percent National PercentCash or self-payment 57.1 95.9Private health insurance -- 48.5Medicare -- 29.4Medicaid -- 62.8State financed insurance (other than Medicaid) -- 32.0Federal military insurance (e.g., VA, TRICARE) -- 17.8Sliding fee scale (based on income and other factors) 14.3 51.1No charge for patients who cannot pay 85.7 33.4








BuprenorphinePuerto Rico DATA Certified Physicians as of March 2010: 256The following map shows the location of the physicians that have waivers in Puerto Rico.





U.S. Virgin Islands The 2009 midyear U.S. Census Bureau population estimate for the U.S. Virgin Islands was 110,000. On March 31, 2008, according to the SAMHSA, CBHSQ, National Survey of Substance Abuse Treatment Services (N-SSATS), there were 59 patients receiving any type of substance abuse treatment in 2 facilities.


Celia Victor

Government of Virgin IslandsBarbel Plaza South, 2nd FloorSt. Thomas, Virgin Islands 00820Phone: (340) 774-4888Fax: (340) 774-4701Email: [email protected]

Profile of Opioid Treatment Programs (OTPs)Total U.S. Virgin Islands Certified Opioid Treatment Programs as of March 2010: 1


Accreditation of OTPs State Percent National PercentThe Joint Commission 100.0 27.0CARF (Commission on Accreditation of Rehabilitation Facilities) -- 66.4




BuprenorphineU.S. Virgin Islands DATA Certified Physicians as of March 2010: 4The following map shows the location of the physicians that have waivers in the U.S. Virgin Islands.





Appendix A Additional Contributions

Contributions by the following SAMHSA staff are greatly appreciated: Cathie Alderks, Ph.D.; Robert Atanda, Ph.D.; Amina Chaudhry, M.D.; Robert Lubran; Mary Lou Ojeda; Nicholas Reuter; Charles Reynolds; and Arlene Stanton, Ph.D.

HHS Publication No. (SMA) 11-4643 Printed 2011

Documents

Medication Assisted Treatment For Opioid …...treatment of opioid addiction. SAMHSA’s Center for Substance Abuse Treatment (CSAT) manages the day-to-day regulatory oversight activities